Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vincent A Carlier"'
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e45366 (2012)
The nature of MHC class II-binding epitopes not only determines the specificity of T cell responses, but may also alter effector cell functions. Cytolytic CD4+ T cells have been observed primarily in anti-viral responses, but very little is known abo
Externí odkaz:
https://doaj.org/article/0d3135624e1d4a3a84bc91babf5da900
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Autoreactive CD4+ T cells recognizing islet-derived antigens play a primary role in type 1 diabetes. Specific suppression of such cells therefore represents a strategic target for the cure of the disease. We have developed a methodology by which CD4+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2390393ce0096b9a7ad1f1f8a5cf2a5c
https://www.frontiersin.org/article/10.3389/fimmu.2018.01600/full
https://www.frontiersin.org/article/10.3389/fimmu.2018.01600/full
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 7 (2016)
Frontiers in Immunology, Vol. 7, p. 67 [1-10] (2016)
Frontiers in Immunology, Vol 7 (2016)
Frontiers in Immunology, Vol. 7, p. 67 [1-10] (2016)
Autoreactive CD4(+) T cells recognizing islet-derived antigens play a primary role in type 1 diabetes. Specific suppression of such cells therefore represents a strategic target for the cure of the disease. We have developed a methodology by which CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30511c1b4e785bd918530490ca47668b
https://pubmed.ncbi.nlm.nih.gov/30034402
https://pubmed.ncbi.nlm.nih.gov/30034402
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Autoreactive CD4+ T cells recognizing islet-derived antigens play a primary role in type 1 diabetes. Specific suppression of such cells therefore represents a strategic target for the cure of the disease. We have developed a methodology by which CD4+
Externí odkaz:
https://doaj.org/article/33678bf5935c483ca04a8d40e543ce5e